Edition:
United Kingdom

JCR Pharmaceuticals to initiate development of JR-171, new drug candidate for Hurler Syndrome using J-Brain Cargo


Thursday, 26 Oct 2017 

Oct 26 (Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:Says it will initiate development of JR-171, new drug candidate for Hurler Syndrome using J-Brain Cargo. 

Company Quote

6060.0
-30.0 -0.49%
1:28am BST